XML 32 R56.htm IDEA: XBRL DOCUMENT v2.4.0.6
SHAREHOLDER'S EQUITY (Details) (USD $)
3 Months Ended 0 Months Ended 3 Months Ended 0 Months Ended 3 Months Ended
Mar. 31, 2013
Dec. 31, 2012
Jan. 17, 2013
Series A LLC Preferred Shares
Mar. 31, 2013
Series A LLC Preferred Shares
Mar. 31, 2013
Restricted common shares
Mar. 31, 2012
Restricted common shares
Feb. 14, 2013
Restricted common shares
Manager
Mar. 31, 2013
Restricted common shares
Manager
Mar. 31, 2012
Restricted common shares
Manager
Mar. 31, 2013
Restricted common shares
Directors
Mar. 31, 2012
Restricted common shares
Directors
Mar. 31, 2013
Common share options
Mar. 31, 2012
Common share options
Stock-based compensation                          
Preferred shares, shares issued 14,950,000 0 14,950,000                    
Preferred shares, dividend rate (as a percent)     7.375% 7.375%                  
Gross proceeds from issue of preferred shares (in dollars)     $ 373,800,000                    
Net proceeds from issuance of preferred stock (in dollars) 361,622,000   362,000,000                    
Exercise price of share options granted, minimum (as a percent)                       100.00%  
Termination period from date of grant                       10 years  
Authorized shares available to satisfy awards as of the balance sheet date                       8,839,625  
Vesting period             3 years            
Restricted common share transactions                          
Unvested shares at the beginning of the period         531,190     438,937   92,253      
Issued (in shares)         292,009   292,009 292,009          
Vested (in shares)         (146,312)     (146,312)          
Unvested shares at the end of the period         676,887     584,634   92,253      
Value of unvested restricted common shares granted (in dollars per share)               $ 11.07 $ 9.21        
Unrecognized compensation cost (in dollars)         5,300,000 3,900,000              
Number of Options                          
Outstanding at the beginning of the period (in shares)                       1,932,279  
Outstanding at the end of the period (in shares)                       1,932,279  
Exercisable at the end of the period (in shares)                       1,932,279 1,932,279
Weighted Average Exercise Price                          
Outstanding at the beginning of the period (in dollars per share)                       $ 20.00  
Outstanding at the end of the period (in dollars per share)                       $ 20.00  
Share-based compensation expense (in dollars)         $ 980,000 $ 614,000   $ 719,000 $ 383,000 $ 261,000 $ 231,000